Collective results from the CDX model strongly support the conclusion that HLTF-deletion in cancer cells with resultant metabolic reprogramming—a hallmark of metastasis—is likely a prototypical example of cancer cells modifying their metabolic requirements in response to Hltf-deletion in the TME. This evidence concerns the gene HLTF and cancer.